Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2022-04-29 Proxy Solicitation & In…
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2022-04-29 English
FORM 10-K/A
Annual Report FY 2021
2022-03-01 English
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Pliant Therapeutics, Inc. It registers shares issuable under stock option and employee stock purchase plans. The document includes legal and indemnification information, exhibits, and undertakings related to the registration of securities. It is not a financial report, earnings release, or management discussion. It is a capital/financing related filing concerning registration of securities for employee benefit plans. Therefore, it fits best under Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not just an announcement or notice, so it is not RPA or RNS.
2022-03-01 English
POS AM
Capital/Financing Update Classification · 100% confidence The document is a Post-Effective Amendment No. 2 to a Registration Statement on Form S-3 filed with the SEC by Pliant Therapeutics, Inc. It is a registration statement related to securities offerings, including common stock, preferred stock, debt securities, warrants, and units. The document includes a base prospectus and a sales agreement prospectus, describing the terms of securities offerings and the registration process under the Securities Act of 1933. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital raising and securities registration. The document is lengthy (15,000 characters) and contains detailed registration and offering information, consistent with a Capital/Financing Update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-03-01 English
8-K/A
Earnings Release Classification · 90% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which is a Current Report. It specifically discusses the issuance of a corrected press release regarding financial results for the fourth quarter and year ended December 31, 2021. The document length is 3685 characters, which is relatively short and primarily serves to amend and correct a previously issued earnings press release. It does not contain the full financial statements or detailed financial analysis itself but references the press release as an exhibit. Therefore, this document is an amendment to a current report primarily announcing corrected earnings information, fitting best under the category of Earnings Release (ER) since it relates to the announcement of quarterly/year-end financial results, even though it is an amendment. The document is not the full annual report or interim report, nor is it a regulatory filing unrelated to earnings. Hence, the classification is ER with high confidence.
2022-03-01 English
10-K
Annual Report FY 2021
2022-03-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.